Enhancing Performance of Early Phase Drug Development Projects

Event Overview

The pharmaceutical industry is widely acknowledged to be facing an R&D productivity crisis. There are constant demands to enhance efficiency, improve productivity and reduce costs all within reduced timelines due to competition from generics and the high attrition rate in clinical studies. Biopharma companies need to inject new drugs into their dwindling R&D pipelines and ensure that poor project management doesn't compound this situation. Many molecules have been delayed or development discontinued through mistakes that could have been avoided.

This makes the development of project management skills and tools combined with their flawless application critical to deliver the best chance of success for a new compound. A well planned and executed project is vital in ensuring the speedy collection of critical data to judge efficacy, safety and the value of progressing the drug candidate to the next level.

However, in drug development it's constantly challenging to identify early on the best candidates and strategic approaches to achieve proof of concept and minimise attrition likelihood in p.III . As drug development becomes increasingly globalised, unexpected delays combined with requests for further studies and communication failure can prevent the timely completion of a project.

"Enhancing Performance of Early Phase Drug Development Projects" will look to examine the current state of project management approaches during pre-clinical to phase II and the improvements that can be made in planning, implementing, and controlling pharma project components. By developing these areas biopharma companies and project teams will be able to minimise the risks associated with a new drug's development, and better reach go/ no go decisions in both small and large molecule drugs.

Why Attend?

This conference will cover how to decide upon early phase research strategies, and the operational project management tools and techniques to be best used:

• Improve strategic decision making to enable multiple project successes.
• Minimise risks generated by advancing a compound's development
• Learn how to execute projects involving varied early phase & remote stakeholders, both internally and externally.
• Clarify project scope & team responsibilities to enable optimum allocation of resources.
• Define project management tools and techniques to better leverage early stage research
• Build effective project teams involving both internal and external resources.

Who will benefit?

• Project Managers and those individuals with project responsibilities in early phase Development
• VPs, Senior Directors and Managers of:
  • Discovery,
  • pre-clinical development,
  • exploratory development,
  • early phase clinical development,
  • clinical science,
  • clinical operations,
  • clinical pharmacology & PK/ PD, drug safety,
  • biomarkers,
  • translational medicine,
  • adaptive research,
  • regulatory affairs,
  • therapy area heads & specialists,

About the Venue & City:

Prague has been the political, cultural, and economic centre of the Czech state for more than a millenium. Since 1992, the extensive historic centre of Prague has been a UNESCO World Heritage site.

It's convenient location in the centre of Europe makes it an excellent location for conferences and meetings. Prague is home to the prestigious Charles University, the oldest and largest University in Central & Eastern Europe as well as the more recent Academy of Sciences of the Czech Republic, making it an important centre for academic development.

Your prestigious speaker panel

A more detailed list of speakers’ names is available on the downloadable agenda. Please "request event agenda" below.